AAAAAA

   
Results: 1-11 |
Results: 11
Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions
Authors: Hattenbach, LO Klais, C Koch, FHJ Gumbel, HOC
Citation: Lo. Hattenbach et al., Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions, OPHTHALMOL, 108(8), 2001, pp. 1485-1492
Central retinal vein occlusion and nonarteritic ischemic optic neuropathy in 2 patients with mild iron deficiency anemia
Authors: Kacer, B Hattenbach, LO Horle, S Scharrer, I Kroll, P Koch, F
Citation: B. Kacer et al., Central retinal vein occlusion and nonarteritic ischemic optic neuropathy in 2 patients with mild iron deficiency anemia, OPHTHALMOLA, 215(2), 2001, pp. 128-131
L-arginine-nitric oxide pathway-related metabolites in the aqueous humor of diabetic patients
Authors: Hattenbach, LO Allers, A Klais, C Koch, F Hecker, M
Citation: Lo. Hattenbach et al., L-arginine-nitric oxide pathway-related metabolites in the aqueous humor of diabetic patients, INV OPHTH V, 41(1), 2000, pp. 213-217
Ophthalmic manifestation of congenital protein C deficiency
Authors: Hattenbach, LO Beeg, T Kreuz, W Zubcov, A
Citation: Lo. Hattenbach et al., Ophthalmic manifestation of congenital protein C deficiency, J AAPOS, 3(3), 1999, pp. 188-190
Intraocular recombinant tissue-plasminogen activator fibrinolysis of fibrin formation after cataract surgery in children
Authors: Klais, CM Hattenbach, LO Steinkamp, GWK Zubcov, AA Kohnen, T
Citation: Cm. Klais et al., Intraocular recombinant tissue-plasminogen activator fibrinolysis of fibrin formation after cataract surgery in children, J CAT REF S, 25(3), 1999, pp. 357-362
Complications after implantation of intraocular devices in patients with cytomegalovirus retinitis
Authors: Guembel, HOC Krieglsteiner, S Rosenkranz, C Hattenbach, LO Koch, FHJ Ohrloff, C
Citation: Hoc. Guembel et al., Complications after implantation of intraocular devices in patients with cytomegalovirus retinitis, GR ARCH CL, 237(10), 1999, pp. 824-829
Visual outcome after treatment with low-dose recombinant tissue plasminogen activator or hemodilution in ischemic central retinal vein occlusion
Authors: Hattenbach, LO Wellermann, G Steinkamp, GWK Scharrer, I Koch, FHJ Ohrloff, C
Citation: Lo. Hattenbach et al., Visual outcome after treatment with low-dose recombinant tissue plasminogen activator or hemodilution in ischemic central retinal vein occlusion, OPHTHALMOLA, 213(6), 1999, pp. 360-366
Intravitreal endoscopic visualization of intraocular ganciclovir devices: Improved long-term treatment of CMV retinitis
Authors: Koch, FHJ Gumbel, HOC Hattenbach, LO Ohrloff, C
Citation: Fhj. Koch et al., Intravitreal endoscopic visualization of intraocular ganciclovir devices: Improved long-term treatment of CMV retinitis, KLIN MONATS, 214(2), 1999, pp. 107-111
Heparin cofactor II deficiency in central retinal vein occlusion
Authors: Hattenbach, LO Klais, C Scharrer, I
Citation: Lo. Hattenbach et al., Heparin cofactor II deficiency in central retinal vein occlusion, ACT OPHTH S, 76(6), 1998, pp. 758-759
Identification of beta-defensins in human conjunctiva
Authors: Hattenbach, LO Gumbel, H Kippenberger, S
Citation: Lo. Hattenbach et al., Identification of beta-defensins in human conjunctiva, ANTIM AG CH, 42(12), 1998, pp. 3332-3332
Absence of hypertensive retinopathy in a Turkish kindred with autosomal dominant hypertension and brachydactyly
Authors: Hattenbach, LO Toka, HR Toka, O Schuster, H Luft, FC
Citation: Lo. Hattenbach et al., Absence of hypertensive retinopathy in a Turkish kindred with autosomal dominant hypertension and brachydactyly, BR J OPHTH, 82(12), 1998, pp. 1363-1365
Risultati: 1-11 |